LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
Salma Parvin(University of Miami), Izidore S. Lossos(University of Miami), Eden Sharabi(University of Miami), Daniel Bilbao(University of Miami), Andrew J. Gentles(Stanford Medicine), Evan R. Roberts(University of Miami), Ramiro E. Verdún(University of Miami), Shlomzion Aumann(University of Miami), Gabriel E. Santiago(University of Miami), Ariel Ramírez-Labrada(University of Miami), Isidro Sánchez-Garcı́a(Instituto de Investigación Biomédica de Salamanca), Jennifer R. Chapman(University of Miami), Natalia Weich(University of Miami), XiaoQing Lu(University of Miami), Elena M. Cortizas(University of Miami), Yu Zhang(Guiyang Medical University), Francisco Vega(The University of Texas MD Anderson Cancer Center)
Cited by 98
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
|Cell|2018|2.4k
The Immune Landscape of Cancer
|Immunity|2019|806
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
|Proceedings of the National Academy of Sciences|2015|360